A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in four European countries: Austria, Belgium, Greece, and Italy
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2019 |
| Reihe/Periodikum: | Journal of Medical Economics ; volume 22, issue 8, page 766-776 ; ISSN 1369-6998 1941-837X |
| Verlag/Hrsg.: |
Informa UK Limited
|
| Schlagwörter: | Health Policy |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26983339 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://dx.doi.org/10.1080/13696998.2019.1606002 |
